Exchange: NASDAQ·Updated 09:30 AM EDT

AFMD Affimed N.V.

$0.0001
$0.00
(0.00%)
Today
Reported EarningsNov 14
Mkt Cap$1,523.00
Vol252.00

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.
47

Neutral Sentiment

How do you feel about AFMD?

Advertisement|Remove ads.